A Translational Phase 1B, 2-Part Study to Evaluate Pharmacokinetics, Safety and Pharmacodynamics of Treatment with ATX-304 Na Salt Tablets.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-505967-36-00

Enrollment

Registered

2023-09-15

Start date

2023-09-15

Completion date

2025-05-07

Last updated

2024-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity with prediabetes or type 2 diabetes mellitus

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026